SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses-Reference-Cited by-同舟云学术

SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses

Published:2012-02 Issue:9 Volume:30 Page:1737-1745
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Lai Lilin,Kwa Sue-Fen,Kozlowski Pamela A.,Montefiori David C.,Nolen Tracy L.,Hudgens Michael G.,Johnson Welkin E.,Ferrari Guido,Hirsch Vanessa M.,Felber Barbara K.,Pavlakis George N.,Earl Patricia L.,Moss Bernard,Amara Rama Rao,Robinson Harriet L.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference43 articles.

1. Induction of CD8+ T cells using heterologous prime-boost immunisation strategies;Schneider;Immunol Rev,1999

2. AIDS vaccines: heterologous prime/boost strategies for raising protective T Cell responses;Robinson;AIDS Rev 2000,2000

3. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine;Amara;Science,2001

4. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys;Liu;Nature,2009

5. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting;Richmond;J Virol,1998

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques;Frontiers in Immunology;2022-07-22

2. A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence;PLOS Pathogens;2022-05-03

3. One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection;Proceedings of the National Academy of Sciences;2021-03-09

4. Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates;Frontiers in Immunology;2021-03-09

5. Priming with DNA Expressing Trimeric HIV V1V2 Alters the Immune Hierarchy Favoring the Development of V2-Specific Antibodies in Rhesus Macaques;Journal of Virology;2020-12-22